Immupharma Share Discussion Threads

[che7win] 22/2/2018 17:16

andyr42,
teddy can make mistakes sometimes as I do all the time.

However, I don't think he is too far wrong this time. I think the MM's are really short of stock here, there has been constant buying on the whole from Friday and they have a deficit to cover IMHO.

The MM's are well short of stock so what did they do? Once buying pressure eased off early afternoon, they were able to drive the share price down a bit and get some sellers.

It's just a healthy breather before we continue recovery upwards IMHO.

Monday night is the IMM presentation, then next Thursday is March 1st! Not long to go now.

[sharedgain] 22/2/2018 17:10

Greenpastures2
The Saloon, The Ned Hotel (www.thened.com) , 27 Poultry, London EC2R 8AJ – Doors Open at 6pm for registration and refreshments with the first presentation to start at 6.30pm. Smart Casual attire.

However, if you haven't received an email confirming your place, I suggest that you call them tomorrow (0203 621 4120); you're unlikely to gain entry without your place being confirmed.

[tosh 123] 22/2/2018 17:04

Greenpastures... Its on Cheapside, pretty much right beside " Bank Tube Station " entrance ..
Its the old Midland Bank building... 100 yards from the Bank of England in the direction of St Pauls... I hope that helps.

[daveburns] 22/2/2018 17:02

hxxps://www.sharesmagazine.co.uk/shares/share/IMM/broker-views

Just Over 200p consensus target price

It’s funny reading this thread when in reality all that’s going to happen is a slow ramp up to the results with ups and downs and then either wipeout or a large increase in value up until either full approval or buyout where share price will go crazy

[greenpastures2] 22/2/2018 16:50

In case I don't hear from Turner Pope before I have to leave home on Monday does any one have the address of the presentation?

[ny boy] 22/2/2018 16:45

Do you really think they would announce results at the end of March ie. Thursday 29 March the next day being Good Friday & Easter, I don’t think IMM are that daft 😂

[2prsimo] 22/2/2018 16:42

I thought results were due by the end of March at the latest? - happy to be corrected

[ny boy] 22/2/2018 16:40

2Prismo, no just small time retail investors banking some profits, also where do you get 4/5 weeks, actually only 16 trading days from tomorrow until the start of the week before Easter, which by my recogning is the latest week IMM would announce as the following week, many are on holiday for Easter as it’s a shortened trading week.

So 16 trading days only until trading week commencing Monday 19 Narch

Only 4 trading days until March too!

We really are getting that close now

[growthinvestor2001] 22/2/2018 16:36

I know the short term share price is not really that relevent but it was disspointing to see it at ~133p all day until the buying started drying up after lunch (guessing the short squeeze had finished but no evidence) but to see last trade on google 25296 shares @125p is a bit of a shocker

[2prsimo] 22/2/2018 16:31

Yes, I didn't like the look of that at the end there - could be a very long 4-5 weeks here!

[teddy boy1] 22/2/2018 16:31

I strongly expect the share price to get taken down over the next couple of days to encourage selling ,to replenish some of the many.shares bought in the last 48 hours.

[jimmmy] 22/2/2018 16:29

trying to short again looks like

[abbotslynn] 22/2/2018 16:28

A share to watch

[hottingup] 22/2/2018 16:26

DOW Jones strongly up today. Tree shake just before close. More mugs seperated from their shares.

[hottingup] 22/2/2018 16:13

We have the good Phase 2b Lupuzor results, cheaper pricing, positive comments from patients who took it, and management expecting it to be better and safer than Benlysta.

Phase 3 results out soon, meanwhile IMM's chairman is presenting on Monday evening.

[njb67] 22/2/2018 16:09

HK
Luckily for us it is this board instead....

[njb67] 22/2/2018 16:04

Growth
They are not allowed to. It would be considered promotional and they do not have a licence for Lupuzor. Would get them into a lot of trouble with the regulators.

[ny boy] 22/2/2018 16:01

Ask Tim..Is that a Gucci suit you’re wearing?

[njb67] 22/2/2018 15:55

sharedgain 20 Feb '18 - 11:02 - 14715

Some questions for the investor meeting on Monday. I am most interested in getting a better handle on potential revenue streams, which will underpin the valuation attributed to IMM.

Best wishes


1. How do you plan to use the £10m raised during the recent placing?

2. You have been quoted as saying that Lupuzor could hit an annual revenue of a billion pounds? Over what time frame do you believe this could be achieved?

3. You mention that you are in discussions with a number of interested pharmaceutical companies. Can you elaborate on why you have not yet secured a commercial partner? What attempts have you made to secure a commercial partner since the annulment of your agreement with Cephalon?

4. IMM is quite a small company. Are you able to launch Lupuzor without a commercial partner? Would the lack of a commercial partner delay your plans to launch in 2018?

5. If the Lupuzor phase 3 study is successful, how quickly would IMM be able to develop Lupuzor for other indications? When could we realistically see a second indication come to market?

6. How advanced are the Nucant and Urelix development progammes? When could we realistically see the first products come to market?